These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6102466)

  • 1. In vivo blockade of dopaminergic receptors from different rat brain regions by classical and atypical neuroleptics.
    Le Fur G; Guilloux F; Uzan A
    Biochem Pharmacol; 1980 Feb; 29(3):267-70. PubMed ID: 6102466
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo occupancy of dopamine receptors by antipsychotic drugs.
    Meltzer HY; Stockmeier CA
    Arch Gen Psychiatry; 1992 Jul; 49(7):588-9. PubMed ID: 1352678
    [No Abstract]   [Full Text] [Related]  

  • 3. Antipsychotic drug effects on dopamine and serotonin receptors: in vitro binding and in vivo turnover studies.
    Bacopoulos NG
    J Pharmacol Exp Ther; 1981 Dec; 219(3):708-14. PubMed ID: 6170752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of repeated treatment with neuroleptics on dopamine metabolism in cell bodies and terminals of dopaminergic systems in the rat brain.
    Scatton B
    Adv Biochem Psychopharmacol; 1980; 24():31-6. PubMed ID: 6105783
    [No Abstract]   [Full Text] [Related]  

  • 5. Central nervous system dopamine receptors.
    Creese I
    Adv Biochem Psychopharmacol; 1980; 21():235-42. PubMed ID: 6103649
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential sensitivity to neuroleptic drugs of cerebral dopamine receptors following chronic treatment of rats with trifluoperazine.
    Dawbarn D; Pycock C
    Eur J Pharmacol; 1981 May; 71(2-3):233-45. PubMed ID: 6113967
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of carbidine on the dopamine and serotonin receptors of the central nervous system].
    Zharkovskiĭ AM; Klassen NE; Zharkovskiĭ TA
    Biull Eksp Biol Med; 1985 Jun; 99(6):700-2. PubMed ID: 2861866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of timiperone on 3H-spiroperidol binding to rat striatal dopamine receptors.
    Tachizawa H; Sudo K; Sano M
    Eur J Pharmacol; 1979 Nov; 59(3-4):245-51. PubMed ID: 43256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dopaminergic receptors, multiple targets for neuroleptics].
    Martres MP; Sokoloff P; Giros B; Bouthenet ML; Pilon C; Lannfelt L; Schwartz JC
    Ann Med Psychol (Paris); 1992; 150(2-3):119-23. PubMed ID: 1364189
    [No Abstract]   [Full Text] [Related]  

  • 10. New insights into the biology of schizophrenia through the mechanism of action of clozapine.
    Brunello N; Masotto C; Steardo L; Markstein R; Racagni G
    Neuropsychopharmacology; 1995 Nov; 13(3):177-213. PubMed ID: 8602893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irreversible blockade of [3H]spiperone- but not [3H]dopamine-labeled dopamine receptors with phenoxybenzamine.
    Titeler M
    Biochem Pharmacol; 1981 Nov; 30(22):3031-7. PubMed ID: 7337719
    [No Abstract]   [Full Text] [Related]  

  • 12. Biochemical and pharmacological activities of zetidoline (DL 308-IT): a new antidopaminergic agent.
    Barone D; Corsico N; Diena A; Restelli A; Glässer A; Rodenghi F
    J Pharm Pharmacol; 1982 Feb; 34(2):129-32. PubMed ID: 6121878
    [No Abstract]   [Full Text] [Related]  

  • 13. The complexity of dopamine receptors and psychopharmacotherapy in children.
    Guérin P; Barthélémy C; Garreau B; Héraut J; Muh JP; Lelord G
    Acta Paedopsychiatr; 1993; 56(2):139-51. PubMed ID: 7510920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine receptor blockade by imidoline and its proposed active conformation.
    Koe BK; Koch SW; Dominy BW
    Eur J Pharmacol; 1980 Nov; 68(2):139-46. PubMed ID: 6110542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic continuous administration of neuroleptic drugs alters cerebral dopamine receptors and increases spontaneous dopaminergic action in the striatum.
    Murugaiah K; Theodorou A; Mann S; Clow A; Jenner P; Marsden CD
    Nature; 1982 Apr; 296(5857):570-2. PubMed ID: 6122161
    [No Abstract]   [Full Text] [Related]  

  • 16. Some atypical neuroleptics inhibit [3H]SCH 23390 binding in vivo.
    Andersen PH; Nielsen EB; Grønvald FC; Braestrup C
    Eur J Pharmacol; 1986 Jan; 120(1):143-4. PubMed ID: 2868903
    [No Abstract]   [Full Text] [Related]  

  • 17. [Functional role and pharmacological regulation of the dopaminergic system of the brain].
    Raevskiĭ KS
    Vestn Ross Akad Med Nauk; 1998; (8):19-24. PubMed ID: 9771125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.
    Florijn WJ; Tarazi FI; Creese I
    J Pharmacol Exp Ther; 1997 Feb; 280(2):561-9. PubMed ID: 9023264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and pharmacological differentiation of neuroleptic effect on dopamine D-1 and D-2 receptors.
    Hyttel J; Christensen AV
    J Neural Transm Suppl; 1983; 18():157-64. PubMed ID: 6135740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of antipsychotic drugs on dopamine-receptors on caudate calf].
    Guo QY
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Oct; 25(5):296-9, 317-8. PubMed ID: 1363315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.